Endoxan N 1000mg Injection (Cyclophosphamide 1000mg)

Description

Endoxan N 1000 mg Injection is an anticancer agent that is used alone or in combination with other medications for the treatment of different types of malignant cancers. Close monitoring of kidney function and the blood cell count is necessary while receiving this medication.

Substitutes

List of substitutes for Endoxan N 1000 mg Injection
Cycloxan 1000 mg Injection
Zydus Cadila
Endoxan 1000 mg Injection
Zydus Cadila
Oncophos 1000 mg Injection
Cadila Pharmaceuticals Ltd.

Side effects

Major & minor side effects for Endoxan N 1000 mg Injection
Black or tarry stools
Pain at the injection site
Hair loss
Fever and chills
Weakness
Loss of appetite
Nausea and Vomiting
Diarrhea
Headache
Increased sweating
Skin rash

Uses of Endoxan N 1000 mg Injection

What is it prescribed for?
Malignant cancers
This medicine is used for the treatment of different types of malignant cancers such as multiple myeloma (cancer that affects plasma cells), certain types of leukemia (blood cancer), including chronic lymphocytic leukemia, acute myeloid leukemia, acute lymphoblastic leukemia, and acute myelogenous leukemia, Hodgkin’s lymphoma and non-Hodgkin’s lymphoma (types of cancer that affects certain cells called lymphocytes of the lymphatic system), ovarian cancer (cancer that affects the female reproductive system), breast cancer, retinoblastoma (eye cancer), etc.

Related Products

List of related products
Endoxan 1000 mg Injection
Endoxan 200 mg Injection
Endoxan 50 mg Tablet
Endoxan 500 mg Injection
Endoxan 500 mg Tablet
Endoxan N 200 mg Injection
Endoxan N 500 mg Injection

When not to use?

Allergy
This medicine is not recommended for use in patients with a known allergy to Cyclophosphamide, other alkylating agents, or any other inactive ingredients present along with the formulation.
Urinary outflow obstruction
This medicine is not recommended for use in patients with urinary flow obstruction or cystitis (inflammation of the urinary bladder) due to the increased risk of worsening of the patient’s condition.
Bone marrow suppression
This medicine is not recommended in patients with severe bone marrow suppression (decrease in the production of blood cells).

Dosage

Missed Dose
Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low. If you miss an appointment for a scheduled dose of this medicine, contact your doctor immediately for further instructions.
Overdose
Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.

General Instructions

This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. It should be given in multiple cycles along with other chemotherapy agents. It is important to receive every scheduled dose. The blood cells count and kidney function should be assessed before starting the treatment. Any signs and symptoms of heart and lung dysfunction should be reported to the doctor on priority. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.